Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Schering AG and Astex enter drug discovery collaboration

May 8, 2003

Updated phase II results for Tocosol Paclitaxel

May 8, 2003

Progress made in Bexxar review

May 8, 2003

Introgen gains license to fus1 anticancer gene

May 8, 2003

Viventia's first armed antibodies to enter phase I clinical testing

May 7, 2003

FDA grants accelerated approval of Iressa for NSCLC

May 7, 2003

Antitumor apoptolidin derivative with enhanced stability

May 7, 2003

Schering patent covers new CDK and/or GSK-3beta inhibitors

May 7, 2003

Australian authorities approve Iressa for NSCLC

May 6, 2003

Advectus reports preliminary results for preclinical brain cancer trials

May 6, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...